Clinical Trial Update: A Study to Assess the Change in Disease State in Adult Participants Being Treated With Oral Upadacitinib Tablets in Participants With Oligo- or Poly-artIcular Psoriatic Arthritis

View source ↗

Summary

A completed clinical trial evaluating how Upadacitinib affects disease state in adults with oligo- or poly-articular psoriatic arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• Upadacitinib (upadacitinib)

Snippet

Sponsor: AbbVie | Conditions: Psoriatic Arthritis | Status: COMPLETED